155661-03-3 | Tricosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecen-1-yl]- | C40H79 N O3 |
155661-02-2 | Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-14-methyl-3-pentadecen-1-yl]-21-methyl- | C40H79 N O3 |
155661-04-4 | Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-15-methyl-3-hexadecen-1-yl]-21-methyl- | C41H81 N O3 |
155661-10-2 | 2(3H)-Furanone,dihydro-3-[[4-hydroxy-3-[2-(4-hydroxy-3-methoxyphenyl)-1-(hydroxymethyl)-2-oxoethyl]-5-methoxyphenyl]methyl]-4-[(4-hydroxy-3-methoxyphenyl)methyl]-,(3R,4R)-rel- | C30H32 O10 |
155661-09-9 | 2(3H)-Furanone,dihydro-4-[[4-hydroxy-3-[2-(4-hydroxy-3-methoxyphenyl)-1-(hydroxymethyl)-2-oxoethyl]-5-methoxyphenyl]methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]-,(3R,4R)-rel- | C30H32 O10 |
155661-15-7 | 2H-1-Benzopyran-6-ol,2-[(3E)-4,8-dimethyl-3,7-nonadien-1-yl]-3,4-dihydro-2,8-dimethyl- | C22H32 O2 |
155661-21-5 | staunoside E | C66H108 O33 |
155661-08-8 | 2(3H)-Furanone,dihydro-3-[[4-[2-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-1-(hydroxymethyl)ethoxy]-3-methoxyphenyl]methyl]-4-[(4-hydroxy-3-methoxyphenyl)methyl]-,(3R,4R)- | C30H34 O10 |
155661-20-4 | staunoside D | C60H98 O29 |
155661-18-0 | 2H,6H-Benzo[1,2-b:5,4-b']dipyran-6-one,10-[(3,3-dimethyloxiranyl)methyl]-5-hydroxy-7-(4-hydroxyphenyl)-2,2-dimethyl-,(-)- (9CI) | C25H24 O6 |
155661-01-1 | Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-pentadecen-1-yl]-21-methyl- | C39H77 N O3 |
155661-19-1 | Phakellistatin 2 (9CI) | C45H61 N7 O8 |
155661-17-9 | 2H,6H-Benzo[1,2-b:5,4-b']dipyran-6-one,7-(2,4-dihydroxyphenyl)-10-[(3,3-dimethyloxiranyl)methyl]-5-hydroxy-2,2-dimethyl-,(+)- (9CI) | C25H24 O7 |